Literature DB >> 9093614

Meningitis outbreaks and vaccination strategy.

F Varaine1, D A Caugant, J Y Riou, M K Kondé, G Soga, D Nshimirimana, G Muhirwa, D Ott, E A Høiby, F Fermon, A Moren.   

Abstract

Three outbreaks of meningitis caused by Neisseria meningitidis serogroup A (subgroup III) are described: Niger (1991), Burundi (1992), and Guinea (1993). These outbreaks showed unusual characteristics: a shorter inter-epidemic interval (Niger), unusual geographical location outside the meningitis belt (Burundi and Guinea), and high age-specific attack rates in all age groups (Burundi and Guinea). Mass immunization campaigns mobilized considerable human and financial means (US $322,000 and 3000 person-days of work for health personnel to immunize 629,000 people in Guinea). The vaccination coverage was over 80% in densely populated areas (Burundi and urban Guinea), but below 50% in less populated areas (24/27 and 26/30 sub-districts in Niger and Guinea, respectively). The preventive fraction (proportion of cases prevented by vaccination) was substantial in Guinea (35% for a vaccine efficacy of 85%) and was higher where the campaign was initiated earlier. An 'alert' threshold indicating the onset of an epidemic of 15/100,000 cases in one week showed good sensitivity (94%), specificity (98%) and positive predictive value (89%) in Burundi, permitting quick decision making outside the meningitis belt. These 3 meningococcal meningitis outbreaks show the need for epidemic emergency preparedness and for vigilance on the whole African continent.

Entities:  

Mesh:

Year:  1997        PMID: 9093614     DOI: 10.1016/s0035-9203(97)90371-0

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  9 in total

1.  A Bayesian network approach to the study of historical epidemiological databases: modelling meningitis outbreaks in the Niger.

Authors:  A Beresniak; E Bertherat; W Perea; G Soga; R Souley; D Dupont; S Hugonnet
Journal:  Bull World Health Organ       Date:  2012-01-20       Impact factor: 9.408

Review 2.  Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa.

Authors:  Idris Mohammed; Garba Iliyasu; Abdulrazaq Garba Habib
Journal:  Pathog Glob Health       Date:  2017-01-12       Impact factor: 2.894

Review 3.  Review of the cost effectiveness of immunisation strategies for the control of epidemic meningococcal meningitis.

Authors:  Mark A Miller; Cathryn K Shahab
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 4.  Meningococcal vaccines. Current status and future possibilities.

Authors:  H Peltola
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

Review 5.  The Contributions of Onchocerciasis Control and Elimination Programs toward the Achievement of the Millennium Development Goals.

Authors:  Caitlin Dunn; Kelly Callahan; Moses Katabarwa; Frank Richards; Donald Hopkins; P Craig Withers; Lucas E Buyon; Deborah McFarland
Journal:  PLoS Negl Trop Dis       Date:  2015-05-21

6.  Updating the evidence base on the operational costs of supplementary immunization activities for current and future accelerated disease control, elimination and eradication efforts.

Authors:  Gian Gandhi; Patrick Lydon
Journal:  BMC Public Health       Date:  2014-01-22       Impact factor: 3.295

7.  Meningococcal disease and climate.

Authors:  Helena Palmgren
Journal:  Glob Health Action       Date:  2009-11-11       Impact factor: 2.640

8.  Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world.

Authors:  Jaspreet Toor; Susy Echeverria-Londono; Xiang Li; Kaja Abbas; Emily D Carter; Hannah E Clapham; Andrew Clark; Margaret J de Villiers; Kirsten Eilertson; Matthew Ferrari; Ivane Gamkrelidze; Timothy B Hallett; Wes R Hinsley; Daniel Hogan; John H Huber; Michael L Jackson; Kevin Jean; Mark Jit; Andromachi Karachaliou; Petra Klepac; Alicia Kraay; Justin Lessler; Xi Li; Benjamin A Lopman; Tewodaj Mengistu; C Jessica E Metcalf; Sean M Moore; Shevanthi Nayagam; Timos Papadopoulos; T Alex Perkins; Allison Portnoy; Homie Razavi; Devin Razavi-Shearer; Stephen Resch; Colin Sanderson; Steven Sweet; Yvonne Tam; Hira Tanvir; Quan Tran Minh; Caroline L Trotter; Shaun A Truelove; Emilia Vynnycky; Neff Walker; Amy Winter; Kim Woodruff; Neil M Ferguson; Katy Am Gaythorpe
Journal:  Elife       Date:  2021-07-13       Impact factor: 8.140

Review 9.  The cost and public health burden of invasive meningococcal disease outbreaks: a systematic review.

Authors:  Andrea Anonychuk; Gloria Woo; Andrew Vyse; Nadia Demarteau; Andrea C Tricco
Journal:  Pharmacoeconomics       Date:  2013-07       Impact factor: 4.981

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.